Ruxolitinib for the Treatment of Steroid-Refractory Chronic ...

01/27/21 - JAMA Network Open

AccessHope’s Vice President and Executive Clinical Director Joseph Alvarnas, MD, published a study in JAMA Network Open highlighting the use of a new treatment for the potentially life-ending chronic graft-vs-host disease (cGVHD) resulting from allogeneic hematopoietic stem cell transplantation (HSCT).

Read more

Reimagining Cancer Care Delivery—and Serving Employers—Through ...

12/18/20 - AJMC

AccessHope Board Chair Dr. Harlan Levine spoke with AJMC’s Evidence-Based Oncology™ on the evolution of employers’ interest in cancer care, and the role they are playing to connect employees with leading-edge research.

Read more

Breakthrough Cancer Therapies Offer Hope for Patients

12/09/20 - U.S. News

City of Hope’s Dr. Michael Caligiuri discussed how AccessHope works with employers to provide access to NCI center expertise and assists local oncologists to help develop treatment plans for employees.

Read more

AccessHope Partners With Northwestern to Expand Cancer Expertise ...

11/30/20 - Healthcare Innovation

AccessHope recently announced a novel collaboration with Northwestern Medicine to extend remote delivery of world-renowned cancer expertise and help more people achieve the best possible outcomes. CEO Mark Stadler shares the details.

Read more

Supporting Employees With Cancer

11/27/20 - Employee Benefits & Wellness Excellence

AccessHope CEO Mark Stadler shares how forward-thinking employers are prioritizing experience, outcomes and value in employee cancer care benefits.

Read more

High-Value Care, Workplace Flexibility Aid Employees with Cancer

10/26/20 - SHRM

This piece cites AccessHope as an example of how employers are partnering with centers of excellence and other innovators to tackle cancer challenges in the workplace.

Read more

City of Hope Launches $40M Subsidiary

10/07/20 - Becker's Hospital Review

Becker’s Hospital Review spotlights AccessHope’s formal launch as an employee health care benefit that connects cancer patients and their families with expertise from NCI-designated Comprehensive Cancer Centers.

Read more

Previous